Evidence map›Paper›PMID 40337545›Full record

ArticleSurgical case reports2025

Recurrent Tumor in Colorectal Cancer Requiring Combined Resection of Iliac or Femoral Vessels: Report of Four Cases.

Kentaro Abe, Hiroaki Nozawa, Katsuyuki Hoshina, Toshio Takayama, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Kensuke Kaneko, Takuro Shirasu and 10 more

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kentaro AbeDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroaki NozawaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Katsuyuki HoshinaDepartment of Vascular Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshio TakayamaDepartment of Vascular Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kazuhito SasakiDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Koji MuronoDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shigenobu EmotoDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yuichiro YokoyamaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kensuke KanekoDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takuro ShirasuDepartment of Vascular Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shinya AbeDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yuzo NagaiDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masaru KimuraDepartment of Vascular Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takahide ShinagawaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yuichi TachikawaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Satoshi OkadaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Munetoshi HinataDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Akiko TakaseDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRecurrent tumors in colorectal cancer may be removed along with adjacent blood vessels to achieve R0 resection. However, it remains unclear whether to aggressively perform this procedure because it may cause serious intraoperative or postoperative complications. CASE PRESENTATION: In Case 1, a 62-year-old man underwent radical surgery for rectosigmoid cancer. Three years later, computed tomography scans revealed a disseminated nodule near the left external iliac vessels. We resected the tumor and vessels that were reconstructed by bypass surgery. Histologically, the margins of the tumor were in contact with the adventitia of the vessels. In Case 2, a 63-year-old man underwent radical surgery for ascending colon cancer. A nodule was detected at the right iliac fossa 16 years later and appeared to invade the right femoral vessels. After systemic chemotherapy, the nodule was removed with partial resection of the right femoral artery and vein that were reconstructed by end-to-end anastomosis and bypass surgery, respectively. Histologically, the tumor was located 0.7 mm from the vessels. In Case 3, a 67-year-old woman underwent radical multivisceral resection for obstructive rectosigmoid cancer invading the adjacent organs. Fifteen months later, she developed local recurrence and subsequently received chemotherapy. She underwent en bloc resection of the tumor and the left internal iliac artery (IIA) near the bifurcation. The left external iliac artery was reconstructed by end-to-end anastomosis. Direct invasion of the IIA was proven histologically. In Case 4, a 74-year-old woman underwent radical surgery for ascending colon cancer with high microsatellite instability. Eight months later, a recurrent tumor was detected near the right external iliac vessels. After pembrolizumab and chemoradiotherapy, we resected the tumor and part of the external iliac vein; the defect was primarily closed with sutures. No viable tumor cells were found in the specimen. During the follow-up period (median: 52 months), 3 patients were alive without vascular surgery-related complications.

conclusionsIt is difficult to accurately evaluate whether a recurrent tumor from colorectal cancer directly invades vessels using preoperative imaging. However, the combined resection of recurrent tumor and vessels may be required to achieve R0 resection, considering a short distance even in invasion-negative cases.

Indexed as

colorectal cancercombined resectionsrecurrent tumorvascular invasion

Identifiers

PMID40337545
PMCPMC12056520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.